The single highest-leverage piece of intelligence a home care seller can have heading into a process is which private equity firms are likely to pay the most for their specific business. Buyer-type matching — by sub-sector, geography, EBITDA size, payer mix, and growth profile — is the difference between a competitive process clearing at the top of the multiple range and a one-buyer conversation clearing at the bottom.
Below are profiles of the private equity firms most actively buying in home-based care in 2026: their active platforms, sweet-spot agency size, sub-sector focus, and what they typically want in a seller.
Note: PE firm activity changes quarterly. The profiles below reflect Hendon Partners’ direct dialogue with each firm and tracked deal activity through Q2 2026. We update our internal database continuously and tailor each engagement to the most current buyer landscape.
How to Use This Guide
PE firms vary along three axes that matter for sellers:
Check size and stage — platform vs. tuck-in, equity check ranges, fund size
Sub-sector focus — personal care, home health, hospice, IDD, ABA/autism, behavioral health, pediatric
The right buyer for an agency is the firm whose active mandate matches the agency’s profile today. Wrong-fit outreach destroys time and tips off the market without producing bids.
Tier 1: Most Active Home-Based Care PE Buyers in 2026
Alpine Investors
HQ: San Francisco
Fund size (current): $4.5B+ (Fund IX)
Home care platforms: Multiple in personal care and home health
Sweet spot: $3M–$15M EBITDA platforms; tuck-ins of any size
Sub-sector focus: Personal care, home health, hospice
Investment thesis: People-first buy-and-build. Heavy emphasis on developing CEOs from within, operator-led growth, and culture preservation.
What they want from sellers: Founder willing to engage in transition; clean books; growth runway; equity rollover preferred
Notable for sellers: Among the most disciplined cultural diligence in the market. Sellers who care about post-close legacy often align well.
Blue Wolf Capital
HQ: New York
Fund size: $1.5B+ recent fund
Home care platforms: Active in hospice and home health consolidation
Sweet spot: $5M–$25M EBITDA platforms; tuck-ins to portfolio
Sub-sector focus: Hospice, home health, multi-service home-based care
Investment thesis: Healthcare services consolidation with operational improvement focus
What they want from sellers: Strong management depth; clean compliance; willingness to be part of platform vision
Notable for sellers: Highly active in hospice; experienced in CHOW execution across multiple states
Kinderhook Industries
HQ: New York
Fund size: $2.5B+ recent fund
Home care platforms: Multiple home-based care holdings; Enhabit-related transaction context
Sweet spot: Large platforms ($10M+ EBITDA); selective on tuck-ins
Sub-sector focus: Healthcare services, home-based care
Investment thesis: Buy-and-build with a focus on multi-site healthcare services
What they want from sellers: Scaled platforms with management depth; significant rollover often expected
Notable for sellers: Capable of executing very large transactions; appropriate for sellers at platform scale
The Vistria Group
HQ: Chicago
Fund size: $3B+ recent fund
Home care platforms: Strong activity in behavioral health, IDD, and adjacent home-based care
What they want: Scaled operators with platform potential
Nautic Partners
HQ: Providence
Focus: Middle market healthcare services
Sub-sector activity: Home-based care, behavioral health, healthcare services
Sweet spot: $5M–$20M EBITDA
What they want: Operator-led platforms; founder transitions
General Atlantic
HQ: New York
Focus: Growth equity, larger transactions
Notable transaction: TEAM Services-related activity
Sweet spot: Large platforms ($20M+ EBITDA)
What they want: Established platforms with national scale potential; appropriate for upper-middle-market sellers
Centerbridge Partners
HQ: New York
Focus: Diversified — opportunistic in healthcare
Sweet spot: Large platforms
What they want: Scale and complexity
Genstar Capital
HQ: San Francisco
Focus: Middle market across multiple sectors
Sub-sector activity: Healthcare services, business services
Sweet spot: $10M+ EBITDA
What they want: Buy-and-build platforms with established management
Tier 3: Independent Sponsors and Smaller PE — Active in $1M–$5M EBITDA Range
The mid-market and lower-middle-market home care segment is increasingly active with independent sponsors, family offices, and emerging PE firms. These buyers are often the right fit for first-time sellers in the $1M–$5M EBITDA range where Tier 1 funds prefer tuck-ins to existing platforms.
Categories include:
Healthcare-focused independent sponsors — typically backed by family offices, often founder-friendly
Family offices direct-investing in home care — long hold horizons, often less rollover pressure
Search funds led by healthcare operators — single-asset acquirers, founder-friendly
A specialized advisor curates this set carefully — it changes constantly and not all sponsors close at announced terms.
Strategic Acquirers Sellers Should Also Know
While this guide focuses on PE, strategic acquirers continue to drive a meaningful share of mid-market home care M&A. The most active in 2026 include:
Help at Home (PE-backed, Centerbridge & Vistria) — personal care consolidation
Addus HomeCare (NASDAQ: ADUS) — multi-service home-based care
BrightSpring Health Services (NASDAQ: BTSG) — home care, pharmacy, behavioral health
Aveanna Healthcare (NASDAQ: AVAH) — pediatric and adult home health
Pennant Group (NASDAQ: PNTG) — hospice and home health
Enhabit (NYSE: EHAB) — Medicare home health
Optum / UnitedHealth Group — Medicare home health (Amedisys-pending)
HCSG, Senior Helpers, BrightStar — selective franchise and corporate-led acquisitions
Strategic buyers value differently than PE — typically with a synergy lens that can produce higher net multiples for the right asset.
How to Match Your Agency to the Right Buyer
Five variables drive buyer-fit in home care M&A:
1. Service Line
Personal care: Alpine, Help at Home, Addus, BrightSpring, Audax portfolio
Medicare home health: Webster, Blue Wolf, Pennant, Enhabit, Optum
Hospice: Webster, Blue Wolf, Pennant, BrightSpring portfolio
IDD: Vistria, BrightSpring, Linden
ABA / Autism therapy: Vistria, Charlesbank, Linden, Audax portfolio
Behavioral health: Vistria, Charlesbank, Linden
Pediatric home health: Aveanna, Vistria, BAYADA-affiliated buyers
$1M–$3M: Tier 1 PE platform tuck-ins, smaller strategic add-ons
$3M–$10M: Tier 1 and Tier 2 PE add-ons; platform launches in some sub-sectors
$10M+: New platform launches; mega-fund interest
3. Geography
CON states: Limited buyer set — premium pricing for transferable certificates
Sunbelt growth markets: Broadest buyer interest
Mature Northeast / Midwest: Strategic and PE consolidator focus
4. Payer Mix
Medicare-heavy: Different buyer pool than Medicaid-heavy
MLTSS / managed Medicaid: Increasingly favored by PE
Private pay-heavy: Highest valuations historically; specific buyer set
5. Owner Post-Close Intentions
Full exit, fast: Strategics and select PE
Rollover and stay: PE platforms (most prefer this structure)
Partial liquidity, continue running: PE majority recapitalization
What Sellers Get Wrong About PE Buyers
Mistake #1: Approaching one firm directly.
Single-firm conversations forfeit the leverage that drives valuation. The right move is a curated, competitive process across 8–15 well-matched firms.
Mistake #2: Assuming the biggest fund pays the most.
The biggest fund is often the worst fit for a $2M EBITDA agency. Right-sized PE pays the best price.
Mistake #3: Believing the headline multiple.
PE multiples come with structure: rollover, earnout, working capital pegs, escrow. The seller’s net cash at close is what matters — and that requires structural negotiation.
Mistake #4: Not vetting closing track record.
Some PE firms have higher pull rates between LOI and close than others. Recent closing track record is a critical buyer-quality signal.
Mistake #5: Underestimating the post-close relationship.
Rollover means you are partners with this PE firm for 3–7 years. Cultural fit during diligence is not a soft factor — it is a financial one.
How Hendon Partners Matches Sellers to PE Buyers
For each engagement, Hendon Partners curates the buyer list to the subset of PE firms most likely to pay a premium for that specific combination of service line, geography, EBITDA size, payer mix, and seller goals.
We maintain active dialogue with 200+ qualified buyers across home-based care — including every firm profiled above and dozens more not listed publicly. Our role is to convert that intelligence into competitive process design that drives the best price and structure for the seller.
Hendon Partners is a specialized home care M&A advisory firm. The buyer profiles above reflect our direct market engagement and tracked transaction activity through Q2 2026.
Frequently Asked Questions
Which private equity firms are most actively buying home care in 2026?
+
The most active PE buyers in home-based care in 2026 include Alpine Investors, Blue Wolf Capital, Kinderhook Industries, The Vistria Group, Webster Equity Partners, Audax Group, Linden Capital, Charlesbank, Nautic Partners, and General Atlantic. Each focuses on different sub-sectors and check sizes — alignment between seller profile and PE firm thesis often matters more than headline reputation.
What size agency does private equity buy in home care?
+
PE platform investments typically require $3M–$15M+ of EBITDA. Tuck-in acquisitions to existing PE platforms are made at any size from $250K EBITDA upward. Agencies with $1M–$3M EBITDA generally trade to PE-backed platforms as add-ons, while $5M+ EBITDA agencies often trade as new platform investments at higher multiples.
How is a PE buyer different from a strategic buyer in home care?
+
Strategic buyers (operators like Help at Home, Addus, BrightSpring) value cost synergies and integration into an existing operating footprint. PE buyers value standalone EBITDA, growth potential, and the founder's willingness to roll equity and stay engaged. PE typically pays higher headline multiples but expects more rollover and post-close engagement.
Should I approach a private equity firm directly?
+
Almost never. Sellers who approach a single PE firm directly forfeit competitive leverage and typically close 20–40% below market. A specialized M&A advisor runs a competitive process across the right subset of PE firms — matching your specific service line, geography, and EBITDA size to the firms most likely to bid aggressively.
Do PE firms require sellers to roll equity?
+
Most PE platforms require some level of rollover equity (typically 10–35% of equity value) when acquiring a founder-led platform. Tuck-in acquisitions to existing platforms often allow for full cash exits. The rollover requirement varies by firm, by deal structure, and by the seller's ongoing role post-close.
